A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy
Condition(s):Metastasis of Malignant Neoplasm to Lymph NodeLast Updated:March 11, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Metastasis of Malignant Neoplasm to Lymph NodeLast Updated:March 11, 2019Unknown status
Condition(s):Gynecological Tumor; Adaptive Radiotherapy; Radiation; Curative Treatment; Optimization; Adaptive Radiation Therapy; Image Guided Radiotherapy; Cervical CarcinomaLast Updated:February 9, 2024Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:April 4, 2011Unknown status
Condition(s):Adjuvant RadiotherapyLast Updated:February 22, 2024Not yet recruiting
Condition(s):Gastric CancerLast Updated:May 9, 2011Unknown status
Condition(s):Radiation DermatitisLast Updated:September 6, 2023Completed
Condition(s):Clear Cell Metastatic Renal Cell CarcinomaLast Updated:March 23, 2021Completed
Condition(s):Brain Metastases; RadiotherapyLast Updated:January 5, 2024Not yet recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:June 22, 2023Not yet recruiting
Condition(s):Brain Metastases, Adult; Central Nervous System MetastasesLast Updated:July 27, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.